Retrospective Evaluation of Infusion Tolerability: Ublituximab Real-World Observational Survey (ENAMOR) By admin / 04/07/2025
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series By admin / 04/03/2025
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function By admin / 04/03/2025
Safety and Tolerability of 30-minute Ublituximab Infusions: Updates from the ENHANCE Study By admin / 02/27/2025
The Design of a Study to Evaluate Fc Biology and Genetic Diversity in Multiple Sclerosis By admin / 02/27/2025
